| Literature DB >> 29318403 |
Nicholas R V Jones1, Nita G Forouhi1, Kay-Tee Khaw2, Nicholas J Wareham1, Pablo Monsivais3,4.
Abstract
The dietary approaches to stop hypertension (DASH) diet could be an important population-level strategy to reduce cardiovascular disease (CVD) in the UK, but there is little UK-based evidence on this diet pattern in relation to CVD risk. We tested whether dietary accordance with DASH was associated with risk of CVD in a population-based sample of 23,655 UK adults. This prospective analysis of the EPIC-Norfolk cohort study analysed dietary intake (assessed using a validated food frequency questionnaire) to measure accordance with DASH, based on intakes of eight food groups and nutrients, ranking the sample into quintiles. Cox proportional hazards regression models tested for association between DASH accordance and incident stroke, ischemic heart disease (IHD) and total incident CVD (stroke and IHD only), as well as CVD mortality, non-CVD mortality and total mortality. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated adjusting for age, sex, behavioral and clinical risk factors and socioeconomic status. Over an average of 12.4 years follow-up, we ascertained 4129 incident CVD events, of which stroke accounted for 1011. Compared to participants with the least DASH-accordant diets, those with the most DASH-accordant diets had 20% lower risk of incident stroke (HR, 95% CI 0.80, 0.65-0.99) and 13% lower risk of total incident CVD (0.88, 0.79-0.99) but no lower risk of CHD (0.90, 0.79-1.02). CVD-related mortality also showed strong inverse associations with DASH accordance (0.72, 0.60-0.85). This study provides evidence for the cardioprotective effects of DASH diet in a UK context.Entities:
Keywords: Cardiovascular; DASH; Diet; Food; ICD-10; Prevention; Stroke
Mesh:
Year: 2018 PMID: 29318403 PMCID: PMC5871645 DOI: 10.1007/s10654-017-0354-8
Source DB: PubMed Journal: Eur J Epidemiol ISSN: 0393-2990 Impact factor: 8.082
Fig. 1Flow diagram illustrating selection of the analytical sample
Comparison of analytical sample and excluded cases
| Included | Excluded | |
|---|---|---|
| Mean age (years) | 59.1 | 61.3 |
| % Male | 45.6 | 40.9 |
| % Current smoker | 11.5 | 15.1 |
| Mean BMI | 26.3 | 26.9 |
| % Inactivea | 29.7 | 42.9 |
| Mean weekly units of alcohol | 7.2 | 6.2 |
| Semi- and non-skilled occupational social classb | 16.5 | 24.6 |
| % Single | 3.9 | 6.1 |
| % Diabetesc | 2.3 | 2.7 |
| % Anti-hypertensive medicationd | 18.5 | 22.5 |
| % Lipid lowering medicatione | 1.5 | 1.4 |
| Mean total serum cholesterol (mmol/L) | 6.2 | 6.3 |
| Mean LDL cholesterol (mmol/L) | 3.9 | 4.0 |
| Mean HDL cholesterol (mmol/L) | 1.4 | 1.4 |
| Mean systolic blood pressure (mmHg) | 135.3 | 137.4 |
| Mean diastolic blood pressure (mmHg) | 82.5 | 83.3 |
| % Least accordant DASH quintile | 24.3 | 26.7 |
aLowest category of physical activity; blowest two occupational social groups, based on the Registrar General classification; cself-reported past diagnosis of diabetes; duse of any medications indicated for hypertension; euse of any medications indicated for high cholesterol or dislipidemia
Characteristics of the analytical sample (n = 23,655; EPIC-Norfolk Cohort)
| Quintile of accordance to DASH | |||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | |
| Number | 5744 | 5227 | 3703 | 4800 | 4181 |
|
| |||||
| Mean age (years) | 59.7 | 59.4 | 58.9 | 59.1 | 58.0 |
| % Male | 58 | 50 | 44 | 40 | 33 |
| % Current smoker | 19 | 12 | 10 | 8 | 6 |
| % Overweight and obese | 62 | 62 | 62 | 59 | 55 |
| % Inactivea | 34 | 32 | 31 | 28 | 22 |
| Mean weekly units of alcohol | 7.2 | 7.4 | 7.2 | 7.3 | 6.7 |
| Semi- and non-skilled occupational social classb | 22 | 16 | 16 | 14 | 13 |
| % Single | 4.1 | 3.6 | 3.8 | 3.7 | 4.1 |
| % Diabetesc | 1.5 | 1.7 | 2.8 | 2.7 | 2.9 |
| % Anti-hypertensive medicationd | 17 | 19 | 20 | 19 | 18 |
| % Lipid lowering medicatione | 1.0 | 1.4 | 1.6 | 1.5 | 2.3 |
| % History of CVDf | 4.5 | 4.7 | 4.1 | 4.0 | 4.4 |
|
| |||||
| Systolic blood pressure (mmHg) | 136.8 | 136.1 | 134.7 | 135.0 | 133.5 |
| Diastolic blood pressure (mmHg) | 83.4 | 82.8 | 82.2 | 82.2 | 81.5 |
| Total cholesterol (mmol/L) | 6.23 | 6.19 | 6.18 | 6.19 | 6.07 |
| HDL cholesterol (mmol/L) | 1.35 | 1.39 | 1.42 | 1.45 | 1.49 |
| LDL cholesterol (mmol/L) | 4.02 | 3.98 | 3.97 | 3.97 | 3.84 |
|
| |||||
| Number of incident IHD events | 975 | 818 | 520 | 624 | 494 |
| Number of incident stroke events | 318 | 262 | 157 | 209 | 150 |
| Number of CVD deaths | 479 | 423 | 264 | 289 | 192 |
aLowest category of physical activity; blowest two occupational social groups, based on the Registrar General classification; cself-reported past diagnosis of diabetes; duse of any medications indicated for hypertension; euse of any medications indicated for high cholesterol or dislipidemia; frecorded cardiovascular disease event
Hazard ratios and 95% confidence intervals for incident ischaemic heart disease, incident cerebrovascular disease and incident cardiovascular disease, by quintile of DASH accordance score; (EPIC-Norfolk cohort, n = 23,655)
| Quintile of accordance to DASH | Events per 100,000 person-years | Model 1a | Model 2b | ||
|---|---|---|---|---|---|
|
| |||||
| Q1 | 1262.2 | 1.00 | (Ref.) | 1.00 | (Ref.) |
| Q2 | 1125.0 | 0.95 | (0.86–1.05) | 0.95 | (0.86–1.05) |
| Q3 | 982.6 | 0.88* | (0.79–0.99) | 0.88* | (0.78–0.99) |
| Q4 | 916.2 | 0.85** | (0.76–0.95) | 0.91 | (0.81–1.01) |
| Q5 | 799.7 | 0.87* | (0.77–0.99) | 0.90 | (0.79–1.02) |
|
| |||||
| Q1 | 422.0 | 1.00 | (Ref.) | 1.00 | (Ref.) |
| Q2 | 376.9 | 0.93 | (0.78–1.10) | 0.95 | (0.80–1.12) |
| Q3 | 323.3 | 0.84 | (0.69–1.02) | 0.85 | (0.69–1.04) |
| Q4 | 320.5 | 0.84 | (0.70–1.01) | 0.87 | (0.73–1.05) |
| Q5 | 261.3 | 0.79* | (0.64–0.97) | 0.80* | (0.65–0.99) |
|
| |||||
| Q1 | 1471.7 | 1.00 | (Ref.) | 1.00 | (Ref.) |
| Q2 | 1304.6 | 0.94 | (0.86–1.03) | 0.95 | (0.87–1.04) |
| Q3 | 1154.2 | 0.88* | (0.79–0.98) | 0.89* | (0.80–0.99) |
| Q4 | 1071.2 | 0.85** | (0.77–0.94) | 0.90* | (0.81–0.99) |
| Q5 | 929.5 | 0.85** | (0.76–0.95) | 0.88* | (0.79–0.99) |
*p < 0.05; **p < 0.01;***p < 0.001
aAdjusted for age, sex and dietary energy
bAs Model 1 but further adjusted for smoking status, alcohol intake, physical activity, BMI, diabetes, SES, marital status, use of antihypertensive medication, use of lipid-lowering medication and history of CVD
Hazard ratios and 95% confidence intervals for CVD mortality, non-CVD mortality and all-cause mortality, by quintile of DASH accordance score, (EPIC-Norfolk cohort, n = 23,655)
| Quintile of accordance to DASH | Events per 100,000 person-years | Model 1a | Model 2b | ||
|---|---|---|---|---|---|
|
| |||||
| Q1 | 495.3 | 1.00 | (Ref.) | 1.00 | (Ref.) |
| Q2 | 478.1 | 1.04 | (0.91–1.18) | 1.05 | (0.92–1.20) |
| Q3 | 414.6 | 0.95 | (0.81–1.10) | 0.95 | (0.81–1.10) |
| Q4 | 348.5 | 0.82** | (0.71–0.95) | 0.84* | (0.72–0.98) |
| Q5 | 261.6 | 0.75** | (0.63–0.88) | 0.72*** | (0.60–0.85) |
|
| |||||
| Q1 | 1444.7 | 1.00 | (Ref.) | 1.00 | (Ref.) |
| Q2 | 1300.9 | 0.95 | (0.88–1.03) | 0.99 | (0.91–1.07) |
| Q3 | 1133.9 | 0.86** | (0.79–0.94) | 0.90* | (0.82–0.99) |
| Q4 | 1121.4 | 0.86*** | (0.79–0.93) | 0.93 | (0.85–1.01) |
| Q5 | 976.9 | 0.86** | (0.78–0.94) | 0.93 | (0.85–1.02) |
|
| |||||
| Q1 | 1940.0 | 1.00 | (Ref.) | 1.00 | (Ref.) |
| Q2 | 1779.0 | 0.97 | (0.91–1.04) | 1.01 | (0.94–1.08) |
| Q3 | 1548.5 | 0.88** | (0.82–0.95) | 0.91* | (0.84–0.99) |
| Q4 | 1471.0 | 0.85*** | (0.79–0.91) | 0.91** | (0.84–0.98) |
| Q5 | 1238.5 | 0.83*** | (0.77–0.90) | 0.87** | (0.80–0.95) |
*p < 0.05;**p < 0.01;***p < 0.001
aAdjusted for age, sex and dietary energy
bAs Model 1 but further adjusted for smoking status, alcohol intake, physical activity, BMI, diabetes, SES, marital status, use of antihypertensive medication, use of lipid-lowering medication and history of CVD